EPRX
Price:
$5.87
Market Cap:
$207.73M
Eupraxia Pharmaceuticals Inc., a clinical stage biotechnology company, engages in the discovery, development, and marketing of technologies in the biotechnology sector. The company's lead product candidates are EP-104IAR, which is in a Phase III clinical trial for the treatment of unmet medical needs and for pain relief for knee osteoarthritis; EP-104GI, which is in a Phase II clinical trial for the treatment of eosinophilic esophagitis; and EP-104, under preclinical studies for the treatment of other inflammatory joint conditions, benign structures of the esophagus, and epidural delivery. It also is involved in the development of product candidates for oncology. The company was formerly kno...[Read more]
Industry
Biotechnology
IPO Date
Stock Exchange
NASDAQ
Ticker
EPRX
According to Eupraxia Pharmaceuticals Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -6.67. This represents a change of 47.17% compared to the average of -4.53 of the last 4 quarters.
The mean historical PE Ratio of Eupraxia Pharmaceuticals Inc. over the last ten years is -9.11. The current -6.67 PE Ratio has changed 7.22% with respect to the historical average. Over the past ten years (40 quarters), EPRX's PE Ratio was at its highest in in the June 2022 quarter at -0.87. The PE Ratio was at its lowest in in the December 2020 quarter at -161.13.
Average
-9.11
Median
-5.09
Minimum
-22.21
Maximum
-1.52
Discovering the peaks and valleys of Eupraxia Pharmaceuticals Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 99.39%
Maximum Annual PE Ratio = -1.52
Minimum Annual Increase = -93.17%
Minimum Annual PE Ratio = -22.21
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -3.04 | -12.23% |
| 2023 | -3.47 | 14.58% |
| 2022 | -3.03 | 99.39% |
| 2021 | -1.52 | -93.17% |
| 2020 | -22.21 | 79.53% |
| 2019 | -12.37 | 84.39% |
| 2018 | -6.71 | -67.37% |
The current PE Ratio of Eupraxia Pharmaceuticals Inc. (EPRX) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
-3.18
5-year avg
-6.65
10-year avg
-9.11
Eupraxia Pharmaceuticals Inc.’s PE Ratio is greater than MediWound Ltd. (-6.90), less than Nautilus Biotechnology, Inc. (-4.16), less than NEONC TECHNOLOGIES HOLDINGS, INC. (-3.29), less than Orchestra BioMed Holdings, Inc. (-2.58), less than Aardvark Therapeutics, Inc. Common Stock (-5.52), less than SELLAS Life Sciences Group, Inc. (-6.53), less than Inventiva S.A. (-1.22), less than Cartesian Therapeutics, Inc. (-3.74), less than Genfit S.A. (-5.72), less than Protara Therapeutics, Inc. (-5.71),
| Company | PE Ratio | Market cap |
|---|---|---|
| -6.90 | $195.31M | |
| -4.16 | $261.45M | |
| -3.29 | $182.08M | |
| -2.58 | $264.25M | |
| -5.52 | $269.99M | |
| -6.53 | $183.40M | |
| -1.22 | $217.29M | |
| -3.74 | $179.42M | |
| -5.72 | $290.81M | |
| -5.71 | $265.09M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Eupraxia Pharmaceuticals Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Eupraxia Pharmaceuticals Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Eupraxia Pharmaceuticals Inc.'s PE Ratio?
How is the PE Ratio calculated for Eupraxia Pharmaceuticals Inc. (EPRX)?
What is the highest PE Ratio for Eupraxia Pharmaceuticals Inc. (EPRX)?
What is the 3-year average PE Ratio for Eupraxia Pharmaceuticals Inc. (EPRX)?
What is the 5-year average PE Ratio for Eupraxia Pharmaceuticals Inc. (EPRX)?
How does the current PE Ratio for Eupraxia Pharmaceuticals Inc. (EPRX) compare to its historical average?